The Institute of Medicine estimates around a 100 million Americans suffer with chronic pain, and it’s estimated that about 10% of our population has or has had a substance use disorder. Both chronic pain and substance use disorders are major public health challenges, and treating concurrent pain and substance addiction is especially challenging. Common prescribing practices intended to provide relief of acute and chronic pain can trigger relapse in people with substance use disorders and have also fueled an epidemic of opiod misuse, addiction and overdose death. People with pain deserve relief, and the good news is there are many strategies for both acute and chronic pain management that are safe and effective for people at risk of or in recovery from substance use disorders. This presentation will discuss various methods of pharmacologic and non-pharmacologic pain management and their relative risks and benefits, and describe creative approaches to effective pain relief for people in recovery from substance use disorders.
Naloxone is a medication used to revive a person who has overdosed on opiod drugs until emergency care is available. When given to someone who has overdosed on prescription opioids or heroin, Naloxone can save the person’s life. You can read about naloxone here.
Related reading suggestions: Related reading suggestions will be posted around the presentation date.
Carl Christensen, MD, PhD, FACOG, FASAM, ABAM
Dr. Carl Christensen is a Clinical Associate Professor at the Wayne State University School of Medicine and has a private medical practice in Ann Arbor, Michigan. He obtained his MD and PhD in Biochemistry at Wayne State University School of Medicine and did his residency in Obstetrics and Gynecology at Hutzel Hospital. He then completed a Fellowship in Gynecologic Oncology at Duke University Medical Center. He was Associate Residency Director of the OB Gyn Residency until 2012. He is certified in Addiction Medicine and is a Fellow of the American Society of Addiction Medicine. He is the past president of the Michigan Society of Addiction Medicine and the current Medical Director of the Michigan Health Professional Recovery Program, which monitors impaired nurses, pharmacists and doctors. He is the current Medical Director of the James Wardell Women’s Recovery Center, an outpatient program dedicated to caring for pregnant, chemically dependent women, as well as the Medical Director at the Tolan Medical Research Clinic in the Department of Psychiatry at WSU. He is also the Medical Director for Dawn Farm. Dr. Christensen also specializes in the treatment of chronic pain, especially pelvic pain. He has received numerous teaching awards. He has been named one of the “Top Docs” in Addiction Medicine in Hour Magazine since 2006.
Mark Weiner, MD, DFASAM; Internal Medicine and Addiction Medicine
Dr. Weiner is the Section Chief of Addiction Medicine and serves as the Medical Director of Substance Use Disorders at St. Joseph Mercy Hospital Ann Arbor. He is also the Medical Director of IHA Pain Management Consultants. He is the chair of the planning committee of the American Society of Addiction Medicine course, “Pain and Addiction: Common Threads” and is a member of the planning committee for the American Society of Addiction Medicine Annual Meeting. He is an editor of the upcoming ASAM Pain and Addiction Handbook planned for publication in 2017. Dr. Weiner is the current Chair of the Board of Trustees of Dawn Farm.